Advisory Research’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-5,926
| Closed | -$502K | – | 365 |
|
2018
Q4 | $502K | Sell |
5,926
-2,499
| -30% | -$212K | 0.01% | 294 |
|
2018
Q3 | $1.44M | Sell |
8,425
-6,295
| -43% | -$1.08M | 0.02% | 230 |
|
2018
Q2 | $1.9M | Sell |
14,720
-42
| -0.3% | -$5.43K | 0.03% | 217 |
|
2018
Q1 | $1.52M | Buy |
+14,762
| New | +$1.52M | 0.03% | 235 |
|